Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (19)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
2009 • 3,433 citations
Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results Database
2006 • 1,745 citations
Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval
2010 • 942 citations
Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells
2006 • 699 citations
PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition
2012 • 550 citations
Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy
2009 • 499 citations
Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1
2012 • 479 citations
Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome
2012 • 475 citations
Combining a PI3K Inhibitor with a PARP Inhibitor Provides an Effective Therapy for BRCA1-Related Breast Cancer
2012 • 425 citations
PIK3CA Mutations and Copy Number Gains in Human Lung Cancers
2008 • 409 citations
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
2008 • 325 citations
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer
2010 • 245 citations
Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor–resistant human lung adenocarcinoma
2011 • 159 citations
First-in-human trial of novel oral PARP inhibitor BMN 673 in patients with solid tumors.
2013 • 75 citations
Proteomic Profiling Identifies Pathways Dysregulated in Non-small Cell Lung Cancer and an Inverse Association of AMPK and Adhesion Pathways with Recurrence
2010 • 69 citations
Aberrant Expression of Proteins Involved in Signal Transduction and DNA Repair Pathways in Lung Cancer and Their Association with Clinical Parameters
2012 • 37 citations
Biological Prognostic and Predictive Factors in Lung Cancer
2009 • 29 citations
Novel Systemic Therapies for Small Cell Lung Cancer
2008 • 27 citations
Nonaneurysmal Subarachnoid Hemorrhage
2007 • 12 citations
Cited By (0)
No citing papers found in database